T. Kawai and S. Akira, The role of pattern-recognition receptors in innate immunity: 2 update on Toll-like receptors, Nat Immunol, vol.11, pp.373-384, 2010.

J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque et al.,

. Palucka, Immunobiology of dendritic cells, Annu Rev Immunol, vol.18, pp.767-811, 2000.

F. Peri, M. Piazza, V. Calabrese, G. Damore, and R. Cighetti, Exploring the LPS/TLR4 6 signal pathway with small molecules, Biochemical Society transactions, vol.38, pp.1390-1395, 2010.

P. Georgel, Z. Jiang, S. Kunz, E. Janssen, J. Mols et al.,

. Beutler, Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like 9 receptor 4-dependent pathway, Virology, vol.362, pp.304-313, 2007.

A. Okumura, P. M. Pitha, A. Yoshimura, and R. N. Harty, Interaction between Ebola 11 virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory 12 cytokines and SOCS1, J virol, vol.84, pp.27-33, 2010.

P. Rallabhandi, R. L. Phillips, M. S. Boukhvalova, L. M. Pletneva, K. A. Shirey et al.,

P. Weiss, J. C. Chow, L. D. Hawkins, S. N. Vogel, and J. C. Blanco, Respiratory syncytial 15 virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 16 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires 17 direct interaction with MD-2, vol.3, pp.218-00212, 2012.

A. Tsung, J. R. Klune, X. Zhang, G. Jeyabalan, Z. Cao et al.,

T. R. Rosengart and . Billiar, HMGB1 release induced by liver ischemia involves Toll-like 20 receptor 4 dependent reactive oxygen species production and calcium-mediated signaling, J 21 Exp Med, vol.204, pp.2913-2923, 2007.

Y. Imai, K. Kuba, G. G. Neely, R. Yaghubian-malhami, T. Perkmann et al., , p.23

R. Veldhuizen, Y. H. Leung, H. Wang, H. Liu, Y. Sun et al., , p.24

J. S. Peiris, A. S. Slutsky, S. Akira, M. Hultqvist, R. Holmdahl et al., Identification of oxidative stress and Toll-like receptor 4 signaling 26 as a key pathway of acute lung injury, Cell, vol.133, pp.235-249, 2008.

D. Pal, S. Dasgupta, R. Kundu, S. Maitra, G. Das et al., Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-29 induced insulin resistance, Nat Med, vol.18, p.10, 2012.

N. Stefan and H. U. Haring, The metabolically benign and malignant fatty liver, Diabetes, vol.31, pp.2011-2017, 2011.

R. M. Loftus and D. K. Finlay, Immunometabolism: Cellular Metabolism Turns Immune 33 Regulator, J Biol Chem, vol.291, p.12, 2016.

L. A. Velloso, F. Folli, and M. J. Saad, TLR4 at the Crossroads of Nutrients, Gut 35 Microbiota, and Metabolic Inflammation, Endocrine reviews, vol.36, p.13, 2015.

C. Jin, J. Henao-mejia, and R. A. Flavell, Innate immune receptors: key regulators of 37 metabolic disease progression, Cell metabolism, vol.17, p.14, 2013.

J. Jantsch, D. Chakravortty, N. Turza, A. T. Prechtel, B. Buchholz et al., , p.39

C. Glasner, M. S. Warnecke, K. U. Wiesener, A. Eckardt, M. Steinkasserer et al.,

. Willam, Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-41 induced dendritic cell activation and function, J Immunol, vol.180, p.15, 2008.

O. Warburg, On respiratory impairment in cancer cells, Science, vol.124, p.16, 1956.

N. J. Maciver, R. D. Michalek, and J. C. , Metabolic regulation of T 44 lymphocytes, Annu Rev Immunol, vol.31, p.17, 2013.

J. N. Gnanaprakasam, J. W. Sherman, and R. Wang, MYC and HIF in shaping immune 46 response and immune metabolism, Cytokine Growth Factor Rev, vol.35, p.18, 2017.

I. Siegert, J. Schodel, M. Nairz, V. Schatz, K. Dettmer et al., , p.48

G. Ehrenschwender, A. Schley, J. Beneke, M. Sutter, C. Moll et al., , p.49

R. Katschinski, B. Lang, M. W. Galy, P. Hentze, P. J. Koivunen et al.,

J. Willam and . Jantsch, Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-1, 2015.

, Inducible Factor-1alpha upon LPS Activation in the Presence of Ample Oxygen, Cell reports, vol.2, pp.2048-2055

R. Spirig, S. Djafarzadeh, T. Regueira, S. G. Shaw, C. Garnier et al.,

P. M. Rieben and . Lepper, Effects of TLR agonists on the hypoxia-regulated 5 transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions, 2010.

, PLoS ONE, vol.5, p.10983

S. C. Cheng, J. Quintin, R. A. Cramer, K. M. Shepardson, S. Saeed et al.,

J. H. Bourboulis, N. A. Martens, A. Rao, G. R. Aghajanirefah, Y. Manjeri et al.,

B. M. Arts, . Van-der, P. M. Veer, C. Deen, L. A. Logie et al., , p.10

J. W. Van-der-meer, A. Ng, L. A. Joosten, C. Wijmenga, H. G. Stunnenberg et al.,

G. Netea, 2014. mTOR-and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for 12 trained immunity, Science, vol.345, p.1250684

G. Bajwa, R. J. Deberardinis, B. Shao, B. Hall, J. D. Farrar et al., Cutting Edge: 14 Critical Role of Glycolysis in Human Plasmacytoid Dendritic Cell Antiviral Responses, J 15 Immunol, vol.196, p.22, 2004.

F. Malinarich, K. Duan, R. A. Hamid, A. Bijin, W. X. Lin et al.,

. Connolly, High mitochondrial respiration and glycolytic capacity represent a metabolic 18 phenotype of human tolerogenic dendritic cells, J Immunol, vol.194, p.23, 2015.

M. Cortese, C. Sinclair, and B. Pulendran, Translating glycolytic metabolism to innate 20 immunity in dendritic cells, Cell metabolism, vol.19, p.24, 2014.

B. Everts, E. Amiel, S. C. Huang, A. M. Smith, C. H. Chang et al.,

J. Freitas, G. J. Blagih, M. N. Van-der-windt, R. G. Artyomov, E. L. Jones et al., , p.23

P. , TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon 24 supports the anabolic demands of dendritic cell activation, Nat Immunol, vol.15, p.25, 2014.

B. Everts, E. Amiel, G. J. Van-der-windt, T. C. Freitas, R. Chott et al., Commitment to glycolysis sustains survival of NO-producing 27 inflammatory dendritic cells, Blood, vol.120, p.26, 2012.

B. Everts and E. J. Pearce, Metabolic control of dendritic cell activation and function: 29 recent advances and clinical implications, Frontiers in immunology, vol.5, p.27, 2014.

L. Perrin-cocon, A. Aublin-gex, S. E. Sestito, K. A. Shirey, M. C. Patel et al.,

N. Vogel, F. Peri, and V. Lotteau, TLR4 antagonist FP7 inhibits LPS-induced cytokine 32 production and glycolytic reprogramming in dendritic cells, and protects mice from lethal 33 influenza infection, Scientific reports, vol.7, p.28, 2017.

L. A. O'neill and E. J. Pearce, Immunometabolism governs dendritic cell and 35 macrophage function, J Exp Med, vol.213, p.29, 2016.

C. M. Krawczyk, T. Holowka, J. Sun, J. Blagih, E. Amiel et al., , p.37

C. B. Thompson, R. G. Jones, and E. J. Pearce, Toll-like receptor-induced changes in 38 glycolytic metabolism regulate dendritic cell activation, Blood, vol.115, p.30, 2010.

G. M. Tannahill and L. A. O'neill, The emerging role of metabolic regulation in the 40 functioning of Toll-like receptors and the NOD-like receptor Nlrp3, FEBS Lett, vol.585, p.31, 2011.

M. Schneemann and G. Schoeden, Macrophage biology and immunology: man is not 42 a mouse, J Leukoc Biol, vol.81, p.32, 2007.

R. Cighetti, C. Ciaramelli, S. E. Sestito, I. Zanoni, L. Kubik et al.,

R. Granucci, S. Jerala, J. Martin-santamaria, F. Jimenez-barbero, and . Peri, Modulation 45 of CD14 and TLR4.MD-2 activities by a synthetic lipid A mimetic, European 46 journal of chemical biology, vol.15, p.33, 2014.

L. Perrin-cocon, F. Coutant, S. Agaugue, S. Deforges, P. Andre et al., 48 Oxidized low-density lipoprotein promotes mature dendritic cell transition from 49 differentiating monocyte, J Immunol, vol.167, p.34, 2001.

M. S. Goldberg and P. A. Sharp, Pyruvate kinase M2-specific siRNA induces apoptosis 51 and tumor regression, J Exp Med, vol.209, pp.217-224, 2012.

J. Rius, M. Guma, C. Schachtrup, K. Akassoglou, A. S. Zinkernagel et al.,

G. Haddad and M. Karin, NF-kappaB links innate immunity to the hypoxic response 2 through transcriptional regulation of HIF-1alpha, Nature, vol.453, pp.807-811, 2008.

S. A. Nicholas and V. V. Sumbayev, The role of redox-dependent mechanisms in the 4 downregulation of ligand-induced Toll-like receptors 7, 8 and 4-mediated HIF-1 alpha prolyl 5 hydroxylation, Immunol Cell Biol, vol.88, pp.180-186, 2010.

G. M. Tannahill, A. M. Curtis, J. Adamik, E. M. Palsson-mcdermott, A. F. Mcgettrick et al., , p.7

C. Frezza, N. J. Bernard, B. Kelly, N. H. Foley, L. Zheng et al., , vol.8

M. Haneklaus, B. E. Caffrey, K. Pierce, S. Walmsley, F. C. Beasley et al.,

C. T. Whyte, H. Taylor, S. L. Lin, E. Masters, V. P. Gottlieb et al.,

L. A. Xavier and . O'neill, Succinate is an inflammatory signal that induces IL-1beta 11 through HIF-1alpha, Nature, vol.496, p.53, 2013.

M. Teng, X. P. Jiang, Q. Zhang, J. P. Zhang, D. X. Zhang et al., , p.13, 2012.

, Microtubular stability affects pVHL-mediated regulation of HIF-1alpha via the p38/MAPK 14 pathway in hypoxic cardiomyocytes, PLoS ONE, vol.7, p.35017

D. Kim, J. Dai, Y. H. Park, L. Y. Fai, L. Wang et al., , p.16

X. Luo, Z. Shi, and . Zhang, Activation of Epidermal Growth Factor 17, 2016.

, Receptor/p38/Hypoxia-inducible Factor-1alpha Is Pivotal for Angiogenesis and Tumorigenesis 18 of Malignantly Transformed Cells Induced by Hexavalent Chromium, J Biol Chem, vol.291, p.55

A. Khurana, K. Nakayama, S. Williams, R. J. Davis, T. Mustelin et al., Regulation 21 of the ring finger E3 ligase Siah2 by p38 MAPK, J Biol Chem, vol.281, p.56, 2006.

E. Hoffmann, O. Dittrich-breiholz, H. Holtmann, and M. Kracht, Multiple control of 23 interleukin-8 gene expression, J Leukoc Biol, vol.72, p.57, 2002.

E. Mills and L. A. O'neill, Succinate: a metabolic signal in inflammation, Trends in cell 25 biology, vol.24, p.58, 2014.

J. S. Moon, S. Hisata, M. A. Park, G. M. Denicola, S. W. Ryter et al., 27 2015. mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome 28 Activation, Cell reports, vol.12, p.59

D. J. Roberts and S. Miyamoto, Hexokinase II integrates energy metabolism and 30 cellular protection: Akting on mitochondria and TORCing to autophagy, Cell death and 31 differentiation, vol.22, pp.248-257, 2015.

D. J. Roberts, V. P. Tan-sah, E. Y. Ding, J. M. Smith, and S. Miyamoto, Hexokinase-II 33 positively regulates glucose starvation-induced autophagy through TORC1 inhibition, Mol Cell, vol.34, p.61, 2014.

R. Salomao, M. K. Brunialti, M. M. Rapozo, G. L. Baggio-zappia, C. Galanos et al.,

. Freudenberg, Bacterial sensing, cell signaling, and modulation of the immune response 37 during sepsis, Shock, vol.38, p.62, 2012.

I. Bettoni, F. Comelli, C. Rossini, F. Granucci, G. Giagnoni et al., Glial 39 TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist 40 in a model of peripheral nerve injury in mice, Glia, vol.56, p.63, 2008.

M. De-paola, S. E. Sestito, A. Mariani, C. Memo, R. Fanelli et al.,

F. Calabrese and . Peri, Synthetic and natural small molecule TLR4 antagonists inhibit 43 motoneuron death in cultures from ALS mouse model, Pharmacological research, vol.103, p.64, 2016.

A. Tripathy, S. Khanna, P. Padhan, S. Smita, S. Raghav et al., Direct recognition 46 of LPS drive TLR4 expressing CD8+ T cell activation in patients with rheumatoid arthritis, Scientific reports, vol.47, p.65, 2017.

H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin et al., TLR4 links innate 49 immunity and fatty acid-induced insulin resistance, J Clin Invest, vol.116, pp.3015-3025, 2006.